1 / 19

NCEP/Framingham risk scores: Estimate of 10-yr CHD risk in men without CHD

Age (y) 20–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 Points –9 –4 0 3 6 8 10 11 12 13. Points Total-C Age (y) (mg/dL) 20–39 40–49 50–59 60–69 70–79 <160 0 0 0 0 0 160–199 4 3 2 1 0 200–239 7 5 3 1 0 240–279 9 6 4 2 1 ≥280 11 8 5 3 1. HDL-C (mg/dL) Points

sugar
Télécharger la présentation

NCEP/Framingham risk scores: Estimate of 10-yr CHD risk in men without CHD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Age (y) 20–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 Points –9 –4 0 3 6 8 10 11 12 13 PointsTotal-C Age (y)(mg/dL) 20–39 40–49 50–59 60–69 70–79 <160 0 0 0 0 0 160–199 4 3 2 1 0 200–239 7 5 3 1 0 240–279 9 6 4 2 1 ≥280 11 8 5 3 1 HDL-C (mg/dL) Points ≥60 –150–59 040–49 1<40 2 Systolic BP Points(mm Hg) Untreated Treated <120 0 0120–129 0 1130–139 1 2140–159 1 2≥160 2 3 Age (y) 20–39 40–49 50–59 60–69 70–79 Nonsmoker 0 0 0 0 0 Smoker 8 5 3 1 1 Point total: <0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 >1710-yr risk (%) <1 1 1 1 1 1 2 2 3 4 5 6 8 10 12 16 20 25 ≥30 VBWG NCEP/Framingham risk scores: Estimate of 10-yr CHD risk in men without CHD Reilly MP, Rader DJ. Circulation. 2003;108:1546-51.

  2. VBWG ATP III update: LDL-C goals and cutpointsfor treatment Risk category LDL-C goal Initiate TLC Consider drug therapy High risk: CHD or CHD risk <100 mg/dL ≥100 mg/dL ≥100 mg/dLequivalents* (10-yr risk >20%) Moderately high risk: 2+ risk factors <130 mg/dL ≥130 mg/dL ≥130 mg/dL (10-yr risk 10%–20%) Moderate risk‡: 2+ risk factors <130 mg/dL ≥130 mg/dL ≥160 mg/dL (10-yr risk <10%) Lower risk‡: 0–1 risk factors <160 mg/dL ≥160 mg/dL ≥190 mg/dL (160–189 mg/dL drugs optional) (optional goal:<70 mg/dL)† (<100 mg/dL;consider drug options) (optional goal:<100 mg/dL) (100–129 mg/dL;consider drug options) *Diabetes or other noncoronary atherosclerotic disease †Favored for very high-risk subset ‡No changes in moderate and lower-risk category TLC = therapeutic lifestyle change Grundy SM et al. Circulation. 2004;110:227-39.

More Related